日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cynaropicrin disrupts tubulin and c-Myc-related signaling and induces parthanatos-type cell death in multiple myeloma

洋蓟苦素破坏微管蛋白和 c-Myc 相关信号并诱导多发性骨髓瘤单核细胞死亡

Joelle C Boulos, Ejlal A Omer, Daniela Rigano, Carmen Formisano, Manik Chatterjee, Ellen Leich, Sabine M Klauck, Le-Tian Shan, Thomas Efferth

Ancistrocladinium A Induces Apoptosis in Proteasome Inhibitor-Resistant Multiple Myeloma Cells: A Promising Therapeutic Agent Candidate

Ancistrocladinium A 诱导蛋白酶体抑制剂耐药多发性骨髓瘤细胞凋亡:一种有前途的治疗药物候选物

Daniela Brünnert, Raina Seupel, Pankaj Goyal, Matthias Bach, Heike Schraud, Stefanie Kirner, Eva Köster, Doris Feineis, Ralf C Bargou, Andreas Schlosser, Gerhard Bringmann, Manik Chatterjee

In Silico, In Vitro, and In Vivo Investigations on Adapalene as Repurposed Third Generation Retinoid against Multiple Myeloma and Leukemia

对阿达帕林作为第三代类视黄酸治疗多发性骨髓瘤和白血病的计算机模拟、体外和体内研究

Joelle C Boulos, Manik Chatterjee, Letian Shan, Thomas Efferth

Disruption of Lipid Raft Microdomains, Regulation of CD38, TP53, and MYC Signaling, and Induction of Apoptosis by Lomitapide in Multiple Myeloma Cells

洛米他派在多发性骨髓瘤细胞中破坏脂筏微区、调节 CD38、TP53 和 MYC 信号传导并诱导细胞凋亡

Mohamed E M Saeed, Joelle C Boulos, Sabrina B Mücklich, Ellen Leich, Manik Chatterjee, Sabine M Klauck, Thomas Efferth

Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma

多发性骨髓瘤患者对抗 BCMA CAR T 细胞产生纯合 BCMA 基因缺失反应

Matteo C Da Vià, Oliver Dietrich, Marietta Truger, Panagiota Arampatzi, Johannes Duell, Anke Heidemeier, Xiang Zhou, Sophia Danhof, Sabrina Kraus, Manik Chatterjee, Manja Meggendorfer, Sven Twardziok, Maria-Elisabeth Goebeler, Max S Topp, Michael Hudecek, Sabrina Prommersberger, Kristen Hege, Shari

Targeting of the E3 ubiquitin-protein ligase HUWE1 impairs DNA repair capacity and tumor growth in preclinical multiple myeloma models

靶向 E3 泛素蛋白连接酶 HUWE1 会损害临床前多发性骨髓瘤模型中的 DNA 修复能力和肿瘤生长

Viktoria Kunz, Kathryn S Bommert, Jessica Kruk, Daniel Schwinning, Manik Chatterjee, Thorsten Stühmer, Ralf Bargou, Kurt Bommert

Novel cell line models to study mechanisms and overcoming strategies of proteasome inhibitor resistance in multiple myeloma

研究多发性骨髓瘤蛋白酶体抑制剂耐药机制及克服策略的新型细胞系模型

Daniela Brünnert, Marianne Kraus, Thorsten Stühmer, Stefanie Kirner, Robin Heiden, Pankaj Goyal, Christoph Driessen, Ralf C Bargou, Manik Chatterjee

Combined PI3K/Akt and Hsp90 targeting synergistically suppresses essential functions of alloreactive T cells and increases Tregs

PI3K/Akt 和 Hsp90 联合靶向可协同抑制同种反应性 T 细胞的基本功能并增加 Treg

Carsten Berges, Tanja Bedke, Claudia Stuehler, Nina Khanna, Sarah Zehnter, Michaela Kruhm, Nadine Winter, Ralf C Bargou, Max S Topp, Hermann Einsele, Manik Chatterjee

PI3K-dependent multiple myeloma cell survival is mediated by the PIK3CA isoform

PI3K 依赖性多发性骨髓瘤细胞存活由 PIK3CA 同工酶介导

Claudia Hofmann, Thorsten Stühmer, Nadine Schmiedl, Reinhard Wetzker, Anja Mottok, Andreas Rosenwald, Christian Langer, Josip Zovko, Manik Chatterjee, Hermann Einsele, Ralf C Bargou, Torsten Steinbrunn

Efficient transient transfection of human multiple myeloma cells by electroporation--an appraisal

电穿孔技术对人类多发性骨髓瘤细胞进行高效瞬时转染的评价

Torsten Steinbrunn, Manik Chatterjee, Ralf C Bargou, Thorsten Stühmer